[Chronic kidney disease: therapy and care]

Rev Prat. 2012 Jan;62(1):43-51.
[Article in French]

Abstract

Chronic kidney disease (CKD) is a major public health problem. It is therefore important to slow its progression and to treat its complications. Regardless of the causal nephropathy, arterial hypertension and proteinuria are the major progression factors of CKD. Thus, optimal control of blood pressure, reduction of proteinuria by using rennin angiotension system inhibitors can slow the progression of CKD. This effect can be enhanced by reducing sodium intake. The recent recommendations suggest that blood pressure should not be higher than 130/80 mmHg and proteinuria should not exceed 0,5 g/day. The consequences of advanced stages of the CKD have to be diagnosed and treated early: anemia, abnormal bone metabolism, hyperkalemia, fluid overload, metabolic acidosis... A particular emphasis has to be given to cardiovascular complications and risk factors. Monitoring data are well defined by the actual recommandations. Nephrologist can provide a set of recommended intervention to the primary care physician. The most accepted criterion of initiation of dialysis, in absence of clinic uremic manifestation is a glomerular filtration rate lower than 7 ml/min/1,73m2. Psychological and medical preparation of the patient to dialysis is essential. The possibility of renal transplantation should be evaluated during the following of patient with CKD

Publication types

  • English Abstract

MeSH terms

  • Algorithms
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Disease Progression
  • Glomerular Filtration Rate
  • Humans
  • Hypertension / etiology
  • Kidney Failure, Chronic / therapy
  • Kidney Transplantation
  • Monitoring, Physiologic
  • Peritoneal Dialysis
  • Proteinuria / etiology
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / therapy*
  • Risk Factors
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors